Study 181-1-06-01 - phase 1A clinical study with DAS181: Double-blind, randomized, placebo-controlled, single dose escalating study in healthy adults

Trial Profile

Study 181-1-06-01 - phase 1A clinical study with DAS181: Double-blind, randomized, placebo-controlled, single dose escalating study in healthy adults

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Nov 2015

At a glance

  • Drugs DAS 181 (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions
  • Sponsors NexBio
  • Most Recent Events

    • 19 Jan 2009 The study was completed in Dec 2008 and the drug was well tolerated at all dosage levels, according to a NexBio media release.
    • 06 Jan 2009 Planned number of patients changed from 60 to 36 as reported by ClinicalTrials.gov.
    • 06 Jan 2009 Status changed from recruiting to completed.as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top